Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma

被引：26
|
作者：
Lee, Min Jung [1 ]
Wickner, Paige [1 ]
Fanning, Laura [1 ]
Schlossman, Robert [2 ]
Richardson, Paul [3 ]
Laubach, Jacob [2 ]
Castells, Maria [1 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 167卷 / 01期
关键词：
allergy; multiple myeloma; myeloma therapy; desensitization; lenalidomide;
D O I：
10.1111/bjh.12925
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：127 / 131
页数：5
相关论文
共 50 条
  • [1] Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma
    Shamriz, Oded
    Parnasa, Elchanan
    Rubin, Limor
    Talmon, Aviv
    Ribak, Yaarit
    Lebel, Eyal
    Vainstein, Vladimir
    Aumann, Shlomzion
    Saban, Revital
    Gatt, Moshe E.
    Tal, Yuval
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (04) : 407 - 413
  • [2] Desensitization to Lenalidomide in a Patient With Relapsed Multiple Myeloma
    Seki, Jack T.
    Banglawala, Sabiha
    Lentz, Emily M.
    Reece, Donna E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (02) : 162 - 165
  • [3] Successful desensitization procedure to lenalidomide in a patient with delayed hypersensitivity confirmed with a positive LTT
    Lazzarato, I.
    Gonzalez-Munoz, M.
    Heredia, R.
    Castellar, F. R.
    Lopez de la Guia, A.
    Cabanas, R.
    Fiandor, A.
    Dominguez-Ortega, J.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 52 (05) : 235 - 237
  • [4] Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center
    Yau, Patrick
    Jimenez-Zepeda, Victor H.
    Bailey, Kyla
    Duggan, Peter
    Tay, Jason
    Bahlis, Nizar J.
    Neri, Paola
    McCulloch, Sylvia
    LEUKEMIA & LYMPHOMA, 2019, 60 (13) : 3199 - 3203
  • [5] Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide
    Yasuyoshi Morita
    Takahiro Shimada
    Terufumi Yamaguchi
    Shinya Rai
    Chikara Hirase
    Masakatsu Emoto
    Kentaro Serizawa
    Yasuhiro Taniguchi
    Mayuko Ojima
    Yoichi Tatsumi
    Takashi Ashida
    Itaru Matsumura
    International Journal of Hematology, 2011, 94 : 583 - 584
  • [6] Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series
    Sugi, Tomiyuki
    Mita, Mitsuo
    Yasu, Takeo
    Ohara, Shin
    Uchida, Tomoyuki
    Inoue, Morihiro
    Hagihara, Masao
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (06) : 1792 - 1795
  • [7] Delayed Cutaneous Hypersensitivity Reactions to Antibiotics Management with Desensitization
    McNulty, Caitlin M. G.
    Park, Miguel A.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2017, 37 (04) : 751 - +
  • [8] Population pharmacokinetics of lenalidomide in multiple myeloma patients
    Guglieri-Lopez, Beatriz
    Perez-Pitarch, Alejandro
    Moes, Dirk Jan A. R.
    Porta-Oltra, Begona
    Climente-Marti, Monica
    Guchelaar, Henk Jan
    Merino-Sanjuan, Matilde
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 189 - 200
  • [9] Population pharmacokinetics of lenalidomide in multiple myeloma patients
    Beatriz Guglieri-López
    Alejandro Pérez-Pitarch
    Dirk Jan A. R. Moes
    Begoña Porta-Oltra
    Mónica Climente-Martí
    Henk Jan Guchelaar
    Matilde Merino-Sanjuán
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 189 - 200
  • [10] Update on the role of lenalidomide in patients with multiple myeloma
    Holstein, Sarah A.
    Suman, Vera J.
    McCarthy, Philip L.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (07) : 175 - 190
12345